DUBLIN, Sept. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown's®2 infant formula solutions. Good Start®, a trusted infant formula brand for over 50 years, and Dr. Brown's®, makers of the No. 1 pediatrician-recommended baby bottle in the U.S.3, share a long-time mission of creating confident feeding experiences for families.Perrigo Announces Good Start® and Dr. Browns® Bran ...

DUBLIN, Sept. 17, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $715 million aggregate principal amount of the Issuer's 6.125% Senior Notes due 2032 (the "USD Notes") and €350 million aggregate principal amount of the Issuer's 5.375% Senior Notes due 2032 (the "Euro Notes" and together with the USD Not ...

DUBLIN, Sept. 12, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the pricing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $715 million aggregate principal amount of the Issuer's 6.125% Senior Notes due 2032 (the "USD Notes") and €350 million aggregate principal amount of the Issuer's 5.375% Senior Notes due 2032 (the "Euro Notes" and together with the USD Not ...

Atkinson joins Perrigo from Haleon plc, where he previously served as Interim General CounselDUBLIN, Sept. 4, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Charles Atkinson as Executive Vice President, General Counsel and Secretary. He is a skilled lawyer with nearly 25 years of experience, mostly within the regulated consumer self-care industry.President and CEO Patrick Lockwood-Taylor commented, "I am ver ...

DUBLIN, Aug. 27, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Piper Sandler Growth Frontiers Conference on Tuesday, September 10 at 10:00 AM CDT. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.About PerrigoPerrigo Company plc (NYSE: PRGO) is a leading provider of ...

DUBLIN, Aug. 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Dr. David Ball as Executive Vice President and Chief Brand and Digital Officer. In this newly created position, Dr. Ball will be responsible for an enterprise-wide marketing strategy that incorporates deep understanding of consumer needs and translates those into winning brand strategies, tactics, and actions. He will also evaluate untapped mark ...

Perrigo Company plc (NYSE:PRGO) Q2 2024 Earnings Conference Call August 2, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial Officer Conference Call Participants Chris Schott - JPMorgan Korinne Wolfmeyer - Piper Sandler Daniel Biolsi - Hedgeye Operator Good morning, ladies and gentlemen, and welcome to the Perrigo Second Quarter 2024 Financial Results Conference Cal ...

Perrigo Company plc (PRGO) reported adjusted earnings of 53 cents per share in the second quarter of 2024, beating the Zacks Consensus Estimate of 48 cents. Earnings were down 15.9% year over year due to discrete tax benefits of nine cents per share in the year-ago period and a negative financial impact of 14 cents from infant formula. Net sales declined 10.7% year over year to $1.07 billion, missing the Zacks Consensus Estimate of $1.13 billion. The downside was due to lower net sales of infant formula and ...

Perrigo (PRGO) reported $1.07 billion in revenue for the quarter ended June 2024, representing a year-over-year decline of 10.7%. EPS of $0.53 for the same period compares to $0.63 a year ago.The reported revenue represents a surprise of -5.79% over the Zacks Consensus Estimate of $1.13 billion. With the consensus EPS estimate being $0.48, the EPS surprise was +10.42%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...

film-coated tablet. Ulipristal ace on Contraceptiv Toles one toblet at the same time every day | --- | --- | --- | --- | --- | --- | --- | |-------|------------------------------------------------------|------------------|-------|-------|-------|-------| | | | | | | | | | | Cempare to the rulrillion of Enfamil' Gentlease' | | | | | | | | | | | | | | | | | | | | | | | | (dist | (HARFEVER FELIEF | | | | | | | Gentle- | | | | | | | | | | | | | | | | | | | | | | | | NEW 212 22/2 2012 11:24 | A 822 | | | | | | - ...